Principal Financial Group Inc. lessened its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 20.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 164,043 shares of the health services provider's stock after selling 42,128 shares during the period. Principal Financial Group Inc. owned 0.27% of Maximus worth $15,282,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in MMS. Vanguard Group Inc. lifted its holdings in shares of Maximus by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider's stock worth $520,922,000 after buying an additional 145,983 shares during the period. Janus Henderson Group PLC raised its holdings in shares of Maximus by 2.1% in the first quarter. Janus Henderson Group PLC now owns 1,254,536 shares of the health services provider's stock valued at $105,255,000 after acquiring an additional 25,825 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Maximus by 7.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider's stock worth $98,904,000 after acquiring an additional 79,092 shares during the period. Van Berkom & Associates Inc. grew its holdings in Maximus by 0.8% during the 2nd quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider's stock worth $98,257,000 after acquiring an additional 8,811 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider's stock valued at $81,878,000 after purchasing an additional 645,760 shares during the period. Hedge funds and other institutional investors own 97.21% of the company's stock.
Insiders Place Their Bets
In other Maximus news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the transaction, the insider now owns 6,567 shares in the company, valued at $607,841.52. The trade was a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.40% of the stock is owned by company insiders.
Maximus Stock Down 2.0 %
Shares of NYSE:MMS traded down $1.58 during trading hours on Friday, hitting $79.18. The company's stock had a trading volume of 1,131,939 shares, compared to its average volume of 366,490. The firm's fifty day moving average price is $89.02 and its 200 day moving average price is $88.17. Maximus, Inc. has a 52 week low of $76.42 and a 52 week high of $93.97. The company has a market capitalization of $4.76 billion, a price-to-earnings ratio of 16.60 and a beta of 0.77. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.59 and a quick ratio of 1.59.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date is Friday, November 15th. Maximus's dividend payout ratio (DPR) is 25.16%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.